Unique FLJ12825: Potential Drug Target Or Biomarker (G440101)

Target Name: FLJ12825

NCBI ID: G440101

FLJ12825

Other Name(s): uncharacterized LOC440101 | Uncharacterized LOC440101

Unique FLJ12825: Potential Drug Target Or Biomarker

FLJ12825 is a protein that is expressed in various tissues throughout the body. It is a part of the LOC440101 gene family, which encodes a protein known as loc440101. Loc440101 is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.

FLJ12825 has been identified as a potential drug target or biomarker due to its unique structure and the effects that have been observed when it is expressed in cell culture models. The protein is characterized by a unique N-terminus that contains a conserved glycine residue and a hydrophobic tail. This tail is known to be involved in protein-protein interactions and may contribute to the protein's stability and localization within the cell.

FLJ12825 has also been shown to have unique expression patterns in various tissues and organs. For example, it is highly expressed in the brain, heart, and pancreas, but is not expressed in the lungs or the liver. This suggests that it may be a potential target for drugs that target these tissues.

In addition to its unique expression patterns, FLJ12825 has also been shown to have unique functional properties. For example, it has been shown to be involved in the regulation of cell adhesion and cell migration. This suggests that it may be a potential drug target for diseases that are characterized by these processes, such as cancer.

FLJ12825 has also been shown to have unique interactions with other proteins in the cell. For example, it has been shown to interact with the protein known as PDZP2, which is a known regulator of cell adhesion. This suggests that FLJ12825 may be a potential drug target for diseases that are characterized by disrupted cell adhesion, such as cancer.

In conclusion, FLJ12825 is a unique protein that has been shown to play a role in various cellular processes. Its unique structure and expression patterns, as well as its unique functional properties and interactions with other proteins, make it a promising candidate for drug targeting or biomarker research. Further research is needed to fully understand the role of FLJ12825 in cellular processes and to determine its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC440101

The "FLJ12825 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ12825 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets